Dysregulation of POPDC1 promotes breast cancer cell migration and proliferation
Open Access
- 21 November 2017
- journal article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 37 (6)
- https://doi.org/10.1042/bsr20171039
Abstract
Breast cancer subtypes such as triple-negative that lack the expression of oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor 2 receptor (HER2), remain poorly clinically managed due to a lack of therapeutic targets. This necessitates identification and validation of novel targets. Suppression of Popeye domain-containing protein 1 (POPDC1) is known to promote tumorigenesis and correlate to poor clinical outcomes in various cancers, and also promotes cardiac and skeletal muscle pathologies. It remains to be established whether POPDC1 is dysregulated in breast cancer, and whether overcoming the dysregulation of POPDC1 could present a potential therapeutic strategy to inhibit breast tumorigenesis. We assessed the potential of POPDC1 as a novel target for inhibiting breast cancer cell migration and proliferation. POPDC1 was significantly suppressed with reduced cell membrane localization in breast cancer cells. Furthermore, functional suppression of POPDC1 promoted breast cancer cell migration and proliferation, which were inhibited by POPDC1 overexpression. Finally, cAMP interacts with POPDC1 and up-regulates its expression in breast cancer cells. These findings suggest that POPDC1 plays a role in breast tumorigenesis and represents a potential therapeutic target or biomarker in breast cancer medicine.This publication has 26 references indexed in Scilit:
- Popeye domain-containing proteins and stress-mediated modulation of cardiac pacemakingTrends in Cardiovascular Medicine, 2013
- cAMP Elevation Down-Regulates β3 Integrin and Focal Adhesion Kinase and Inhibits Leptin-Induced Migration of MDA-MB-231 Breast Cancer CellsBioResearch Open Access, 2012
- Popeye domain containing proteins are essential for stress-mediated modulation of cardiac pacemaking in miceJCI Insight, 2012
- BVES regulates EMT in human corneal and colon cancer cells and is silenced via promoter methylation in human colorectal carcinomaJCI Insight, 2011
- Choosing the right cell line for breast cancer researchBreast Cancer Research, 2011
- Bves Modulates Tight Junction Associated SignalingPLOS ONE, 2011
- Nuclear EGFR contributes to acquired resistance to cetuximabOncogene, 2009
- Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK InhibitionCancer Research, 2009
- Molecular Classification and Molecular Forecasting of Breast Cancer: Ready for Clinical Application?Journal of Clinical Oncology, 2005
- Growth inhibition by 8-chloro cyclic AMP of human HT29 colorectal and ZR-75-1 breast carcinoma xenografts is associated with selective modulation of protein kinase A isoenzymesEuropean Journal of Cancer, 1995